Lumexa Imaging (NASDAQ:LMRI) Trading Down 5.8% – Here’s Why

Shares of Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) fell 5.8% on Monday . The company traded as low as $7.99 and last traded at $8.0050. 572,659 shares traded hands during trading, a decline of 34% from the average session volume of 865,049 shares. The stock had previously closed at $8.50.

Analyst Ratings Changes

LMRI has been the topic of a number of recent analyst reports. Weiss Ratings raised Lumexa Imaging from a “sell (e-)” rating to a “sell (e)” rating in a research note on Monday, June 1st. Barclays decreased their price objective on shares of Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating on the stock in a report on Wednesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $16.00.

Lumexa Imaging Price Performance

The company’s 50 day simple moving average is $8.81.

Insiders Place Their Bets

In other news, Director Brett Brodnax purchased 35,000 shares of Lumexa Imaging stock in a transaction dated Tuesday, May 19th. The shares were bought at an average cost of $7.25 per share, with a total value of $253,750.00. Following the completion of the transaction, the director directly owned 62,027 shares in the company, valued at $449,695.75. This trade represents a 129.50% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.70% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Seven Grand Managers LLC bought a new stake in shares of Lumexa Imaging in the fourth quarter valued at about $11,942,000. Assetmark Inc. bought a new position in shares of Lumexa Imaging during the fourth quarter worth about $36,000. Bank of America Corp DE raised its position in Lumexa Imaging by 1,855,116.7% in the 1st quarter. Bank of America Corp DE now owns 111,313 shares of the company’s stock valued at $957,000 after buying an additional 111,307 shares during the last quarter. Renaissance Technologies LLC bought a new stake in Lumexa Imaging in the 1st quarter valued at approximately $778,000. Finally, Janus Henderson Group PLC boosted its position in Lumexa Imaging by 5.4% during the 1st quarter. Janus Henderson Group PLC now owns 2,100,356 shares of the company’s stock worth $18,063,000 after acquiring an additional 107,903 shares during the last quarter.

Lumexa Imaging Company Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).